Cargando…

Effects of blood flow on the antibacterial efficacy of chlorhexidine and silver sulfadiazine coated central venous catheter: A simulation-based pilot study

BACKGROUND: Chlorhexidine and silver sulfadiazine coated central venous catheters (CSS-CVC) may cause loss of antimicrobial efficacy due to friction between the CVC surface and sheer stress caused by the blood flow. Therefore, the aim of this study was to investigate the antibacterial efficacy of CS...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Yong Huan, Choi, Yoon Ji, Kim, Eung Hwi, Yu, Joon Ho, Seong, Hyun Young, Choi, Sung-uk, Yoon, Seung Zhoo, Huh, Hyub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523804/
https://www.ncbi.nlm.nih.gov/pubmed/32991414
http://dx.doi.org/10.1097/MD.0000000000022218
_version_ 1783588433818550272
author Cui, Yong Huan
Choi, Yoon Ji
Kim, Eung Hwi
Yu, Joon Ho
Seong, Hyun Young
Choi, Sung-uk
Yoon, Seung Zhoo
Huh, Hyub
author_facet Cui, Yong Huan
Choi, Yoon Ji
Kim, Eung Hwi
Yu, Joon Ho
Seong, Hyun Young
Choi, Sung-uk
Yoon, Seung Zhoo
Huh, Hyub
author_sort Cui, Yong Huan
collection PubMed
description BACKGROUND: Chlorhexidine and silver sulfadiazine coated central venous catheters (CSS-CVC) may cause loss of antimicrobial efficacy due to friction between the CVC surface and sheer stress caused by the blood flow. Therefore, the aim of this study was to investigate the antibacterial efficacy of CSS-CVC at various flow rates using a bloodstream model. METHODS: Each CVC was subjected to various flow rates (0.5, 1, 2, and 4 L/min) and wear-out times (0, 24, 48, 72, 96, and 120 hours), and the optical density (OD) 600 after a Staphylococcus aureus incubation test was used to determine the antibacterial effect of CSS-CVC. RESULTS: In the 0.5 L/min group, there was no significant change in the OD600 value up to 120 hours compared with the baseline OD600 value for CSS-CVC (P > .467). However, the OD600 values of CSS-CVC in the 1 L/min (P < .001) and 2 L/min (P < .001) groups were significantly reduced up to 72 hours, while that in the 4 L/min (p < 0.001) group decreased rapidly up to 48 hours. CONCLUSION: This study suggests that there is a doubt whether sufficient antibacterial function can be maintained with prolonged duration of catheter placement.
format Online
Article
Text
id pubmed-7523804
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-75238042020-10-14 Effects of blood flow on the antibacterial efficacy of chlorhexidine and silver sulfadiazine coated central venous catheter: A simulation-based pilot study Cui, Yong Huan Choi, Yoon Ji Kim, Eung Hwi Yu, Joon Ho Seong, Hyun Young Choi, Sung-uk Yoon, Seung Zhoo Huh, Hyub Medicine (Baltimore) 3900 BACKGROUND: Chlorhexidine and silver sulfadiazine coated central venous catheters (CSS-CVC) may cause loss of antimicrobial efficacy due to friction between the CVC surface and sheer stress caused by the blood flow. Therefore, the aim of this study was to investigate the antibacterial efficacy of CSS-CVC at various flow rates using a bloodstream model. METHODS: Each CVC was subjected to various flow rates (0.5, 1, 2, and 4 L/min) and wear-out times (0, 24, 48, 72, 96, and 120 hours), and the optical density (OD) 600 after a Staphylococcus aureus incubation test was used to determine the antibacterial effect of CSS-CVC. RESULTS: In the 0.5 L/min group, there was no significant change in the OD600 value up to 120 hours compared with the baseline OD600 value for CSS-CVC (P > .467). However, the OD600 values of CSS-CVC in the 1 L/min (P < .001) and 2 L/min (P < .001) groups were significantly reduced up to 72 hours, while that in the 4 L/min (p < 0.001) group decreased rapidly up to 48 hours. CONCLUSION: This study suggests that there is a doubt whether sufficient antibacterial function can be maintained with prolonged duration of catheter placement. Lippincott Williams & Wilkins 2020-09-25 /pmc/articles/PMC7523804/ /pubmed/32991414 http://dx.doi.org/10.1097/MD.0000000000022218 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 3900
Cui, Yong Huan
Choi, Yoon Ji
Kim, Eung Hwi
Yu, Joon Ho
Seong, Hyun Young
Choi, Sung-uk
Yoon, Seung Zhoo
Huh, Hyub
Effects of blood flow on the antibacterial efficacy of chlorhexidine and silver sulfadiazine coated central venous catheter: A simulation-based pilot study
title Effects of blood flow on the antibacterial efficacy of chlorhexidine and silver sulfadiazine coated central venous catheter: A simulation-based pilot study
title_full Effects of blood flow on the antibacterial efficacy of chlorhexidine and silver sulfadiazine coated central venous catheter: A simulation-based pilot study
title_fullStr Effects of blood flow on the antibacterial efficacy of chlorhexidine and silver sulfadiazine coated central venous catheter: A simulation-based pilot study
title_full_unstemmed Effects of blood flow on the antibacterial efficacy of chlorhexidine and silver sulfadiazine coated central venous catheter: A simulation-based pilot study
title_short Effects of blood flow on the antibacterial efficacy of chlorhexidine and silver sulfadiazine coated central venous catheter: A simulation-based pilot study
title_sort effects of blood flow on the antibacterial efficacy of chlorhexidine and silver sulfadiazine coated central venous catheter: a simulation-based pilot study
topic 3900
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523804/
https://www.ncbi.nlm.nih.gov/pubmed/32991414
http://dx.doi.org/10.1097/MD.0000000000022218
work_keys_str_mv AT cuiyonghuan effectsofbloodflowontheantibacterialefficacyofchlorhexidineandsilversulfadiazinecoatedcentralvenouscatheterasimulationbasedpilotstudy
AT choiyoonji effectsofbloodflowontheantibacterialefficacyofchlorhexidineandsilversulfadiazinecoatedcentralvenouscatheterasimulationbasedpilotstudy
AT kimeunghwi effectsofbloodflowontheantibacterialefficacyofchlorhexidineandsilversulfadiazinecoatedcentralvenouscatheterasimulationbasedpilotstudy
AT yujoonho effectsofbloodflowontheantibacterialefficacyofchlorhexidineandsilversulfadiazinecoatedcentralvenouscatheterasimulationbasedpilotstudy
AT seonghyunyoung effectsofbloodflowontheantibacterialefficacyofchlorhexidineandsilversulfadiazinecoatedcentralvenouscatheterasimulationbasedpilotstudy
AT choisunguk effectsofbloodflowontheantibacterialefficacyofchlorhexidineandsilversulfadiazinecoatedcentralvenouscatheterasimulationbasedpilotstudy
AT yoonseungzhoo effectsofbloodflowontheantibacterialefficacyofchlorhexidineandsilversulfadiazinecoatedcentralvenouscatheterasimulationbasedpilotstudy
AT huhhyub effectsofbloodflowontheantibacterialefficacyofchlorhexidineandsilversulfadiazinecoatedcentralvenouscatheterasimulationbasedpilotstudy